The FDA Is Failing – Here’s What Needs To Change
Daniel Aaron explains why premarket review isn’t as effective as it once was, how corporations have leveraged loopholes to skirt around regulations, and how the agency can get back on track.
User Fees And Presidential Intrusion: Why The FDA Isn’t More Effective
Daniel Aaron, an FDA researcher, explains the main hurdles the agency faces and how these obstacles put consumers at risk.
